Amoxicillin and Clavulanate Potassium Tablets
Formulation (FDF) · Tablets · 0.25g: 0.125g
Formulation (FDF)Confidentiality：Public
- INN / Generic Name
- Amoxicillin and Clavulanate Potassium Tablets
- Dosage Form
- Tablets
- Strength
- 0.25g: 0.125g
- Therapy Area
- Infectious Diseases
- Indication
- Upper respiratory tract infection; Sinusitis; Tonsillitis; Pharyngitis; Lower respiratory tract infection; Bronchitis acute; Chronic bronchitis exacerbation; Pneumonia; Lung abscess; Urinary tract infection; Cystitis; Urethritis; Pyelonephritis; Prostatitis; Pelvic inflammatory disease; Gonococcal urethritis; Chancroid; Skin infection; Soft tissue infection; Furuncle; Abscess; Cellulitis; Wound infection; Intra-abdominal infection; Otitis media; Osteomyelitis; Sepsis; Peritonitis; Postoperative infection
- Current Status
- Official FDF licensing catalog (UB280)
- GMP Certification
- CN - NMPA
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- Registered (market rights transferable / DCP·NP per market)
- MOQ
- On request
- Lead Time
- On request
- Price Range
- On request
HS Code
3004.903 customs bills on file
Registrable Markets
China
Process / Sequence / Exact Price
- Process Summary
- —
- Exact Price